VistaGen Therapeutics Inc. (VTGN) Dropped -6.8% or -0.07 To Price $0.95 On Wednesday

VistaGen Therapeutics Inc. (VTGN) dropped -6.8% or -0.07 to $0.95. It is approximately 121212 shares traded, which is 41.08% compare to the average total volume 295075. The market cap of VTGN is $21.77 million. The year to date change is -12.07%. The 52 week price range is from $0.69 to $2.65. Price of VTGN have changed 0.99% during last week. It have changed -14.29% over last month, -19.69% over last 3 months, 32.47% over last 6 months and -48.74% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for VTGN is 1.09. It is 14.74% above current price. The 200-day Moving Averages for VTGN is 1.28. It is 34.74% above current price. The 52-week High is 2.65. It is 178.95% from the current price. The 52-week Low is 0.69. It is -27.37% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of VTGN is 6.06 on 2018-04-30. Short % to float is 8.92%. There are some statistics of VTGN. It is has market cap $21.77 million. The share outstanding is 22.90 million. The average volume is 295075. It has 16.42M cash and 353900 in debt. The percent of top 15 Institution holding is 32.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of VTGN is -218.33%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of VTGN is -139.37%.


Share this post